• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MICRO THERAPEUTICS, INC. DBA EV3 AXIUM HELIX; DEVICE, VASCULAR, FOR PROMOTING EMBOLIZATION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MICRO THERAPEUTICS, INC. DBA EV3 AXIUM HELIX; DEVICE, VASCULAR, FOR PROMOTING EMBOLIZATION Back to Search Results
Model Number QC-2-4-HELIX
Device Problems Stretched (1601); Detachment of Device or Device Component (2907)
Patient Problem Foreign Body In Patient (2687)
Event Date 08/26/2022
Event Type  Injury  
Event Description
Medtronic received a report that an axium prime coil was stuck in the sheath, and another axium coil used in the procedure prematurely detached.The patient was undergoing treatment for an unruptured, amorphous aneurysm located in the left cavernous sinus segment.The max diameter was 12.8mm, and the neck diameter was 8.9mm.The patient's blood flow was normal, and their vessel tortuosity was moderate.It was reported that resistance was very large and the coil could not be pushed into the microcatheter.After the coil was withdrawn and they tried to push in vitro, but it could not be pushed out.A replacement coil entered the microcatheter smoothly and embolized in place.During the procedure of embolization, when the surgeon made the re-recovery adjustment, the coil automatically stretched during the recovery process and could not be completely recovered into the microcatheter.Then, the surgeon decided to withdraw the microcatheter and the coil as a whole.During the overall withdrawal, it was found that the coil had been detached and remained in the intracavity of the tumor-bearing artery.Finally, the surgeon pressed the coil left outside the aneurysm with a stent.The surgeon believed that the automatic stretching caused the coil to remain in the blood vessel.The coil was not implanted at the intended location, and no additional medical/surgical intervention was required.The pushwire was not bent or broken.There had been no fric tion/difficulty during delivery of the coil that prematurely detached.The physician had repositioned the coil once, and no detachment attempts had been made.The physician did not rotate the delivery pusher.A continuous flush had been administered. the patient d id not experience any injury or symptoms.The devices were prepared according to the instructions for use (ifu).Ancillary devices include an 8f short sheath, 8f guiding catheter, echelon 10 microcatheter, and synchro.014 guidewire.
 
Manufacturer Narrative
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Event Description
Additional information received reported that during preparation, the introducer sheath held vertically when the implant coil was pulled back inside during hydration.There were no issues that resulted in the damage that was found.
 
Manufacturer Narrative
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Manufacturer Narrative
H3: that based on the device analysis and the reported information, the customer¿s report of ¿coil resistance/stuck in sheath¿ was confirmed.There were no reported issues preparing the axium prime implant coil prior to use per the instructions for use (ifu).Therefore, it is likely that the axium prime implant coil became damaged during preparation, or due to an improper hubbing technique (over tightening of the rhv).Regarding the damage (bends/kinks) found with the pushwire and the damage (stretched/broken) found with the axium prime implant coil damage can occur if the device is advanced against resistance or due to handling.However, the root cause for implant coil resistance could not be determined.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AXIUM HELIX
Type of Device
DEVICE, VASCULAR, FOR PROMOTING EMBOLIZATION
Manufacturer (Section D)
MICRO THERAPEUTICS, INC. DBA EV3
9775 toledo way
irvine CA 92618
Manufacturer (Section G)
MICRO THERAPEUTICS, INC. DBA EV3
9775 toledo way
irvine CA 92618
Manufacturer Contact
glen belmer
9775 toledo way
irvine, CA 92618
6122713209
MDR Report Key15316459
MDR Text Key298865404
Report Number2029214-2022-01463
Device Sequence Number1
Product Code KRD
UDI-Device Identifier00847536037281
UDI-Public00847536037281
Combination Product (y/n)N
Reporter Country CodeCH
PMA/PMN Number
K081465
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 11/08/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberQC-2-4-HELIX
Device Catalogue NumberQC-2-4-HELIX
Device Lot Number223667211
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 08/26/2022
Initial Date FDA Received08/29/2022
Supplement Dates Manufacturer Received08/31/2022
10/12/2022
Supplement Dates FDA Received09/20/2022
11/08/2022
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured01/24/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age72 YR
Patient SexMale
Patient Weight70 KG
-
-